Concomitant LATE-NC in Alzheimer's disease is not associated with increased tau or amyloid-β pathological burden.

The presence of LATE-NC in AD is not associated with an increase in the burden of early or late tau or Aβ pathology. LATE-NC is associated with a lower final MMSE score independent of tau pathology.